Get started

Quoin

QNRX first FDA-approved treatment for Netherton SyndromeQuoin Pharmaceuticals (NASDAQ: QNRX ) is positioned to deliver the first FDA-approved treatment for Netherton Syndrome, a devastating disorder which affects 1 in every 200,000 people worldwide. This month, QNRX Signed Multiple Exclusive Distribution Agreements for in various regions of the globe for its Lead Asset, QRX003, for Netherton Syndrome. JMP Securities Initiated Coverage on Quoin Pharmaceuticals, Ltd. ( QNRX ) with a Market Outperform rating and a price target of 8usd. QNRX is massively oversold having a bullish divergence chart formation and fundamentals that can skyrocket the price to 12 usd in my opinion! Could be a Great buy opportunity at $1.91 today!
NASDAQ:QNRXLong
by TopgOptions
6
QNRX Market Outperform Price Target !!Yesterday, JMP Securities Initiated Coverage on Quoin Pharmaceuticals, Ltd. (QNRX) with a Market Outperform rating and a price target of 8usd. Quoin Pharmaceuticals (NASDAQ: QNRX) is positioned to deliver the first FDA-approved treatment for Netherton Syndrome, a devastating disorder which affects 1 in every 200,000 people worldwide. This month, QNRX Signed Multiple Exclusive Distribution Agreements for in various regions of the globe for its Lead Asset, QRX003, for Netherton Syndrome. My price target is the 12usd resistance.
NASDAQ:QNRXLong
by TopgOptions
4
Quoin Pharmaceuticals also breaks the floor. QNRXAnd has been doing so in succession for some time. Looking for zigzag completion here. We just love small caps here for their phenomenal volatility. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
NASDAQ:QNRXShort
by Rykin_Capital
APOP Cellect Biotechnology Upside PotentialNext time when you see those upside spikes is a chart, that is and extremely bullish sign. Maybe some insider buys! Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology that enables the functional selection of stem cells, and Quoin Pharmaceuticals Inc. (“Quoin”), a privately held specialty pharmaceutical company, today announced that the Boards of Directors of the two companies have unanimously approved a definitive Merger Agreement. (globenewswire.com) Market Cap of only 13.644M. This still has room to grow! If you are interested to test some amazing BUY and SELL INDICATORS which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
ALong
by TopgOptions
2